Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
Status:
Completed
Trial end date:
2008-01-03
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare how one 50 mg tablet of SB-497115 is broken down
in the body by healthy subjects versus subjects with mild, moderate or severe kidney
problems. The study is also being done to 1) check on how well the study drug is tolerated by
healthy subjects versus those with liver problems and 2) to check if liver impairment affects
how the study drug binds to protein in the blood.